Genomma Lab InternacionalB de CV (MEX:LABB) ROCE % : 20.11% (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Genomma Lab InternacionalB de CV's annualized ROCE % for the quarter that ended in Mar. 2024 was 20.11%.

Genomma Lab InternacionalB de CV ROCE % Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV ROCE % Chart

Genomma Lab InternacionalB de CV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

16.73

19.08

17.96

20.44

19.35

Genomma Lab InternacionalB de CV Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															21.90	23.56	20.20	8.83	20.11

Genomma Lab InternacionalB de CV ROCE % Calculation

Genomma Lab InternacionalB de CV's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	2550.492	/	( ( (21606.53 - 9356.443)	+	(20738.487 - 6622.353) )	/ 2 )
	=	2550.492	/	( (12250.087	+	14116.134)	/ 2 )
	=	2550.492	/	13183.1105
	=	19.35 %

Genomma Lab InternacionalB de CV's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	2870.476	/	( ( (20738.487 - 6622.353)	+	(21311.788 - 6886.335) )	/ 2 )
	=	2870.476	/	( ( 14116.134	+	14425.453 )	/ 2 )
	=	2870.476	/	14270.7935
	=	20.11 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Genomma Lab InternacionalB de CV (MEX:LABB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Genomma Lab InternacionalB de CV ROCE % Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomma Lab InternacionalB de CV (MEX:LABB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (MEX:LABB) » Definitions » ROCE %

Traded in Other Exchanges

GNMLF:USA GEKA:Germany

Address

Avenida Antonio Dovalí Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210

Website

https://www.genommalab.com

Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV (MEX:LABB) Headlines

No Headlines